Literature DB >> 26891706

Finite sample pointwise confidence intervals for a survival distribution with right-censored data.

Michael P Fay1, Erica H Brittain1.   

Abstract

We review and develop pointwise confidence intervals for a survival distribution with right-censored data for small samples, assuming only independence of censoring and survival. When there is no censoring, at each fixed time point, the problem reduces to making inferences about a binomial parameter. In this case, the recently developed beta product confidence procedure (BPCP) gives the standard exact central binomial confidence intervals of Clopper and Pearson. Additionally, the BPCP has been shown to be exact (gives guaranteed coverage at the nominal level) for progressive type II censoring and has been shown by simulation to be exact for general independent right censoring. In this paper, we modify the BPCP to create a 'mid-p' version, which reduces to the mid-p confidence interval for a binomial parameter when there is no censoring. We perform extensive simulations on both the standard and mid-p BPCP using a method of moments implementation that enforces monotonicity over time. All simulated scenarios suggest that the standard BPCP is exact. The mid-p BPCP, like other mid-p confidence intervals, has simulated coverage closer to the nominal level but may not be exact for all survival times, especially in very low censoring scenarios. In contrast, the two asymptotically-based approximations have lower than nominal coverage in many scenarios. This poor coverage is due to the extreme inflation of the lower error rates, although the upper limits are very conservative. Both the standard and the mid-p BPCP methods are available in our bpcp R package. Published 2016. This article is US Government work and is in the public domain in the USA. Published 2016. This article is US Government work and is in the public domain in the USA.

Entities:  

Keywords:  Kaplan-Meier estimator; beta product confidence procedure; exact test; mid p-value; survival analysis

Mesh:

Year:  2016        PMID: 26891706      PMCID: PMC4899279          DOI: 10.1002/sim.6905

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  A simple hybrid variance estimator for the Kaplan-Meier survival function.

Authors:  Craig B Borkowf
Journal:  Stat Med       Date:  2005-03-30       Impact factor: 2.373

2.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Authors:  Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona Holmberg; Gretchen Henstorf; C Fred LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

3.  Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.

Authors:  Michael P Fay; Erica H Brittain; Michael A Proschan
Journal:  Biostatistics       Date:  2013-04-30       Impact factor: 5.899

  3 in total
  5 in total

1.  Statistical description for survival data.

Authors:  Zhongheng Zhang
Journal:  Ann Transl Med       Date:  2016-10

2.  Long-Term Survival Following Minimally Invasive Lung Cancer Surgery: Comparing Robotic-Assisted and Video-Assisted Surgery.

Authors:  François Montagne; Zied Chaari; Benjamin Bottet; Matthieu Sarsam; Frankie Mbadinga; Jean Selim; Florian Guisier; André Gillibert; Jean-Marc Baste
Journal:  Cancers (Basel)       Date:  2022-05-25       Impact factor: 6.575

3.  Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.

Authors:  Hannes Jansson; Pim B Olthof; Annika Bergquist; Marjolein A P Ligthart; Silvio Nadalin; Roberto I Troisi; Bas Groot Koerkamp; Ruslan Alikhanov; Hauke Lang; Alfredo Guglielmi; Matteo Cescon; William R Jarnagin; Luca Aldrighetti; Thomas M van Gulik; Ernesto Sparrelid
Journal:  HPB (Oxford)       Date:  2021-04-28       Impact factor: 3.647

4.  Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.

Authors:  Carolina Porras; Sabrina H Tsang; Rolando Herrero; Diego Guillén; Teresa M Darragh; Mark H Stoler; Allan Hildesheim; Sarah Wagner; Joseph Boland; Douglas R Lowy; John T Schiller; Mark Schiffman; John Schussler; Mitchell H Gail; Wim Quint; Rebeca Ocampo; Jorge Morales; Ana C Rodríguez; Shangying Hu; Joshua N Sampson; Aimée R Kreimer
Journal:  Lancet Oncol       Date:  2020-12       Impact factor: 41.316

5.  Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease.

Authors:  Nancy A Niemuth; Dawn Fallacara; Cheryl A Triplett; Sanjay M Tamrakar; Alisha Rajbhandari; Clint Florence; Lucy Ward; Anthony Griffiths; Ricardo Carrion; Yenny Goez-Gazi; Kendra J Alfson; Hilary M Staples; Trevor Brasel; Jason E Comer; Shane Massey; Jeanon Smith; Andrew Kocsis; Jake Lowry; Sara C Johnston; Aysegul Nalca; Arthur J Goff; Amy C Shurtleff; Margaret L Pitt; John Trefry; Michael P Fay
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.